Xylazine Associated Wound Care

AVAILABLE ON-DEMAND

Available on-demand. Login or create an account to register to view the recording.

Description

This training is designed to equip medical treatment teams with the basics of wound assessment and treatment. Topics covered include assessment of wound tissue type, drainage, cleansing, dressing supplies, special considerations for xylazine-related wounds.

Learning Objectives

At the conclusion of this seminar, attendees should be able to:

Identify and describe key characteristics of xylazine-associated wounds and perform a basic wound assessment.
Select appropriate cleansing methods and dressing types based on wound presentation and available resources.
Apply wound care principles in nontraditional or resource-limited settings using a harm-reduction and trauma-informed approach.

Claim Credit & Course Material

How to claim your credits & download handouts for each webinar:

Under the "Course" tab (or "Content" tab):

Complete the required course materials.
Claim your credits by clicking the "Report Credit" or "Request Credit" button on the right above the course materials.

Credit Statement

This webinar has been approved for a maximum 1, AOA Category 1-A CME credits. Physicians should claim only the credit commensurate with the extent of their participation. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA) and AOAAM. The AOAAM is accredited by the AOA to provide continuing medical education for physicians.

Speaker

Raagini Jawa MD, MPH

Dr. Jawa is a clinician investigator at the Center for Research on Health Care at the University of Pittsburgh School of Medicine. She earned her MD-MPH from Boston University and is triple board-certified in internal medicine, infectious diseases, and addiction medicine.

Dr. Jawa's clinical work experiences has included providing co-located HIV primary care, office-based addiction treatment for patients with infectious complications of drug use at major academic medical centers, and complex inpatient management of endovascular and serious bacterial infectious complications of drug use. Her clinical interests include developing novel models of care delivery for people with substance use disorders: low barrier clinics, co-located specialty clinics, integrated care in community settings.

She leads the Harm Reduction Research Collaborative, a lab dedicated to integrating harm reduction into healthcare settings, advocating for evidence-based drug policy reform, and advancing patient-centered care for people who use drugs.

Summary

Availability:

On-Demand

Access expires on Apr 01, 2029

Cost:

Member: $0.00
Non-Member: $35.00
Resident/Intern Member: $0.00
Student Member: $0.00

Credit Offered:

1 AOA Category 1A Credit

Create Account